| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.76 ▼ -4.52% | Yesterday | $7.42 ▼ -4.58% | Tomorrow's SELLAS Life Sciences Group Inc. Common Stock (SLS) setup is anchored to $7.08 and targets $6.76 (-4.52%). The near-term read is downside; watch $7.42 / $4.23 because daily realized volatility is about 6.59%. |
Tomorrow's SELLAS Life Sciences Group Inc. Common Stock (SLS) setup is anchored to $7.08 and targets $6.76 (-4.52%). The near-term read is downside; watch $7.42 / $4.23 because daily realized volatility is about 6.59%. | ||||
| Week | $6.31 ▼ -10.88% | Last Week | $5.01 ▲ +41.32% | The 7-day SELLAS Life Sciences Group Inc. Common Stock model moves from $5.01 to $6.31 (-10.88%). It gives downside momentum context for this stock, so breaks around $7.42 / $4.23 matter more than a single tick. |
The 7-day SELLAS Life Sciences Group Inc. Common Stock model moves from $5.01 to $6.31 (-10.88%). It gives downside momentum context for this stock, so breaks around $7.42 / $4.23 matter more than a single tick. | ||||
| Month | $5.77 ▼ -18.50% | Last Month | $5.22 ▲ +35.63% | The 1-month SELLAS Life Sciences Group Inc. Common Stock target is $5.77 (-18.50%), compared with the live reference near $7.08. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month SELLAS Life Sciences Group Inc. Common Stock target is $5.77 (-18.50%), compared with the live reference near $7.08. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $5.25 ▼ -25.85% | Last Year | $1.63 ▲ +334.36% | The 1-year SELLAS Life Sciences Group Inc. Common Stock scenario points to $5.25 (-25.85%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year SELLAS Life Sciences Group Inc. Common Stock scenario points to $5.25 (-25.85%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.48 ▼ -36.72% | 5 Years Ago | $9.04 ▼ -21.68% | The 5-year SELLAS Life Sciences Group Inc. Common Stock view is $4.48 (-36.72%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year SELLAS Life Sciences Group Inc. Common Stock view is $4.48 (-36.72%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 65.0 | Bullish |
| MACD | -0.10 | Bearish |
| SMA 50 | $6.35 | Mid |
| SMA 200 | $6.00 | Mid |
| EMA 20 | $6.53 | Mid |
| Opening Price | $7.16 | Start Date | 2020-01-02 |
| Day Range | $6.95 – $7.47 | Market Cap | $903.30M |
| Monthly Range | $4.46 – $7.42 | 24h Volume | n/a |
| 90D Range | $3.46 – $7.42 | Circulating | n/a |
| 52W Range | $0.8410 – $7.42 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.